Cradle

About

Cradle develops a generative AI platform for de novo protein design, enabling researchers to create and optimize proteins with desired properties. Their technology utilizes machine learning models trained on proprietary and user-supplied experimental data to generate novel protein sequences and predict their characteristics, accelerating the drug discovery and protein engineering processes. Cradle targets biotechnology and pharmaceutical companies, and their platform aims to reduce the time and cost associated with traditional protein development pipelines by minimizing the need for iterative lab experiments.

Focus Areas

Technology Focus

Key People 3

• S Stef van Grieken
• J Jelle Prins
• E Elise de Reus